INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 423m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago
Corporate insider
RE

Rote William E.

Chief Research OfficerCIK 0001698262

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 2
Max Insider Score43
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
9,100 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Travere Therapeutics, Inc.Chief Research Officer · Dec 29, 2025
0
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A
—
14.0K sh
Apr 13, 2026
Apr 15, 2026
traded Apr 13, 2026
+2d
SEC FORM 4

Evidence

5
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC FORM 4

Evidence

26
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.24M
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC FORM 4

Evidence

43
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.41M
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC FORM 4

Evidence